March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.
Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...
NEW DELHI: As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report highlighted the growing role of non-animal, science-driven testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results